These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38847538)

  • 1. Risk factors and molecular epidemiology of intestinal colonization by carbapenem-resistant Gram-negative bacteria in patients with hematological diseases: a multicenter case‒control study.
    Hu H; Wang Y; Sun J; Wang Y; Zhou J; Shi Q; Han X; Jiang Y; Wu D; Huang X; Yu Y
    Microbiol Spectr; 2024 Jul; 12(7):e0429923. PubMed ID: 38847538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
    Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
    J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients.
    Baier C; Beck M; Panagiota V; Lueck C; Kharazipour D; Hintze SC; Bollin R; Ebadi E; Ziesing S; Eder M; Bange FC; Beutel G
    Antimicrob Resist Infect Control; 2019; 8():160. PubMed ID: 31649817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-derived carbapenem-resistant gram-negative bacterial infections in solid organ transplant recipients: Active surveillance enhances recipient safety.
    Mularoni A; Cona A; Campanella M; Barbera F; Medaglia AA; Cervo A; Cuscino N; Di Mento G; Graziano E; El Jalbout JD; Alduino R; Tuzzolino F; Monaco F; Cascio A; Peghin M; Gruttadauria S; Bertani A; Conaldi PG; Mikulska M; Grossi PA
    Am J Transplant; 2024 Jun; 24(6):1046-1056. PubMed ID: 38342183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal colonization with multidrug-resistant gram-negative bacteria in patients with hematological malignancies: a prospective study.
    Kömürcü B; Tükenmez Tigen E; Toptaş T; Fıratlı Tuğlular T; Korten V
    Expert Rev Hematol; 2020 Aug; 13(8):923-927. PubMed ID: 32574123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
    Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for colonization with multidrug-resistant Gram-negative bacteria and
    Azzini AM; Be G; Naso L; Lambertenghi L; Salerno ND; Coledan I; Bazaj A; Mirandola M; Miotti J; Mazzaferri F; Accordini S; Lo Cascio G; Tacconelli E
    Front Cell Infect Microbiol; 2023; 13():1155320. PubMed ID: 37377644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.
    Maina JW; Mutua JM; Musyoki AM
    BMC Infect Dis; 2024 May; 24(1):522. PubMed ID: 38783175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
    Righi E; Mutters NT; Guirao X; Del Toro MD; Eckmann C; Friedrich AW; Giannella M; Kluytmans J; Presterl E; Christaki E; Cross ELA; Visentin A; Sganga G; Tsioutis C; Tacconelli E
    Clin Microbiol Infect; 2023 Apr; 29(4):463-479. PubMed ID: 36566836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and Genotypic Characterization of Carbapenem-Resistant Gram-Negative Bacilli Pathogens from Hospitals in Ghana.
    Codjoe FS; Donkor ES; Smith TJ; Miller K
    Microb Drug Resist; 2019 Dec; 25(10):1449-1457. PubMed ID: 31237486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development.
    Liao Q; Feng Z; Lin H; Zhou Y; Lin J; Zhuo H; Chen X
    Front Cell Infect Microbiol; 2023; 13():1109418. PubMed ID: 36794004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics of carbapenem-resistant gram-negative bacilli in pediatric patients in China.
    Yin L; Lu L; He L; Lu G; Cao Y; Wang L; Zhai X; Wang C
    BMC Microbiol; 2023 May; 23(1):136. PubMed ID: 37202716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report of carbapenems encoding multidrug-resistant gram-negative bacteria from a pediatric hospital in Gaza Strip, Palestine.
    El Aila NA; Al Laham NA; Doijad SP; Imirzalioglu C; Mraheil MA
    BMC Microbiol; 2024 Oct; 24(1):393. PubMed ID: 39379824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate.
    Massart N; Camus C; Benezit F; Moriconi M; Fillatre P; Le Tulzo Y
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):889-895. PubMed ID: 31898797
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Guo Y; Han R; Jiang B; Ding L; Yang F; Zheng B; Yang Y; Wu S; Yin D; Zhu D; Hu F;
    Microbiol Spectr; 2022 Aug; 10(4):e0185422. PubMed ID: 35862963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study.
    Gao S; Yan R; Zhang S; Li L; Zhang R; Fan J; Qin J; Peng Y; Wan D; Cao W; Bian Z
    J Glob Antimicrob Resist; 2024 Mar; 36():96-104. PubMed ID: 38128727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network).
    Falcone M; Tiseo G; Carbonara S; Marino A; Di Caprio G; Carretta A; Mularoni A; Mariani MF; Maraolo AE; Scotto R; Dalfino L; Corbo L; Macera M; Medaglia AA; d'Errico ML; Gioè C; Sgroi C; Del Vecchio RF; Ceccarelli G; Albanese A; Buscemi C; Talamanca S; Raponi G; Foti G; De Stefano G; Franco A; Iacobello C; Corrao S; Morana U; Pieralli F; Gentile I; Santantonio T; Cascio A; Coppola N; Cacopardo B; Farcomeni A; Venditti M; Menichetti F;
    Clin Infect Dis; 2023 Jun; 76(12):2059-2069. PubMed ID: 36801828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.
    Jean SS; Harnod D; Hsueh PR
    Front Cell Infect Microbiol; 2022; 12():823684. PubMed ID: 35372099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the epidemiology of carbapenem-resistant Gram-negative bacteria in west London and the utility of routinely collected hospital microbiology data.
    Freeman R; Moore LS; Charlett A; Donaldson H; Holmes AH
    J Antimicrob Chemother; 2015 Apr; 70(4):1212-8. PubMed ID: 25525198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.